Location
United States, North America
Cheque size
$100K - $15M
Investment Stage
Pre Seed
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Michael Baran is Executive Director, Worldwide Business Development & Partner at Pfizer Ventures in New York City. He leads equity investments in biotech startups from pre-seed through Series B, with checks ranging from $100 K to $15 million (sweet spot $10 million), and his most recent commitment is to Capstan Therapeutics. He is based in New York. Prior to venture investing, he co-founded Nexomics Biosciences, managed R&D portfolio strategy for Pfizer, and serves as an adjunct assistant professor at Stony Brook University.
Previous investments
ImmunOs Therapeutics
11M |2024
73M |2022
15M |2019
Capstan Therapeutics
180M |2024
100M |2022
VitaDAO
4M |2023
500K |2022
Similar Investors
VG
Varun Gupta
United States, North America
$300K - $500K
Seed
,Series A
,AR
Adrian Nicholas Radu
United States, North America
$3M - $20M
Seed
,Series B
,AD
Ailbhe Dempsey
United States, North America
$25K - $40M
Series B
,Seed
,AC
Austin Clements
United States, North America
$100K - $5M
Seed
,Pre Seed
,CA
Casey Aylward
United States, North America
$15M - $70M
Seed
,Series A
,CT
Catherine Tu
United States, North America
$500K - $2M
Series A
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
